Stocksigma LogoStocksigma Logo

Molbio Diagnostics Q2 FY27 Financial Results and Executive Departure

Molbio Diagnostics reported Q2 FY27 consolidated revenue from operations of ₹2,590.20 Mn, down 55.4% YoY from ₹5,802.67 Mn in Q2 FY26 and 36.6% QoQ from

Molbio Diagnostics Q2 FY27 Financial Results and Executive Departure

Molbio Diagnostics Ltd · Financial Result · 06 Nov 2026, 12:56 am

Molbio Diagnostics Q2 FY27 Financial Results and Executive Departure Molbio Diagnostics reported Q2 FY27 consolidated revenue from operations of ₹2,590.20 Mn, down 55.4% YoY from ₹5,802.67 Mn in Q2 FY26 and 36.6% QoQ from ₹4,083.76 Mn. Consolidated net profit dropped 92.8% YoY to ₹77.01 Mn versus ₹1,068.43 Mn, with diluted EPS sliding to ₹1.33. H1 FY27 consolidated net cash from operations stood at ₹1,671.21 Mn. Separately, Dr. Kuldeep Singh Sachdeva resigned as President & CMO (effective 21st Jan'27), and Rakesh Hulihalli & Associates was appointed Secretarial Auditor for five years.

Original exchange filing (PDF)

More announcements from Molbio Diagnostics Ltd

All Molbio Diagnostics Ltd announcements